The American Gastroenterological Association (AGA) has announced a strategic partnership with Forus, an AI-powered medication access platform, to help reduce delays and barriers that prevent patients with digestive diseases from receiving prescribed therapies. The collaboration aims to improve access to medications by addressing challenges such as prior authorizations, insurance appeals, financial assistance, and pharmacy routing, which frequently delay treatment even when clinical evidence supports the prescribed therapy.
Forus integrates directly into electronic health record (EHR) workflows and automates the medication access process across multiple payers, pharmacies, and drug manufacturers at no cost to providers or patients. By combining Forus’ real-world insights into medication access with AGA’s evidence-based clinical guidance and advocacy efforts, the partnership seeks to identify systemic barriers, strengthen policy advocacy, and provide gastroenterologists with resources to help patients start treatment more quickly.